DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Petzold T, Thienel M, Dannenberg L. , et al.
Rivaroxaban reduces arterial thrombosis by inhibition of FXa-driven platelet activation via protease activated receptor-1.
Circ Res 2020;
126 (04) 486-500
We do not assume any responsibility for the contents of the web pages of other providers.